mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.2 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
NSC 74859 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.2 |
mRNA |
BRD-K03911514 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.2 |
mRNA |
WZ8040 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.2 |
mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.27 |
0.2 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.2 |
mRNA |
IU1 |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.2 |
mRNA |
Panobinostat |
FIMM |
pan-cancer |
AAC |
-0.18 |
0.2 |